Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Oral phospholipidic curcumin in juvenile idiopathic arthritis-associated uveitis.

European journal of ophthalmology·2019

Same author

Retinal arterial macroaneurysm associated with macular pucker.

European journal of ophthalmology·2019

Same author

HYPERREFLECTIVE FOCI AS A PATHOGENETIC BIOMARKER IN CHOROIDEREMIA.

Retina (Philadelphia, Pa.)·2019

Same author

MULTIPLE RETINAL PIGMENT EPITHELIUM APERTURES ASSOCIATED WITH PSEUDO-VITELLIFORM LYMPHOMATOUS MACULOPATHY.

Retinal cases & brief reports·2019

Same author

Subretinal pseudocysts: A novel OCT finding in diabetic macular edema.

American journal of ophthalmology case reports·2019

Same author

Need of education on biosimilars amongst ophthalmologists: combating the nocebo effect.

Eye (London, England)·2019

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

Retinal vein occlusion: current treatment.

Rosangela Lattanzio¹, Ana Torres Gimeno, Maurizio Battaglia Parodi

¹Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy.

Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde

|October 13, 2010

Summary

Retinal vein occlusion (RVO) is a complex eye condition requiring multidisciplinary care. Emerging treatments like anti-VEGF therapies and corticosteroids offer improved visual outcomes beyond traditional laser therapy.

More Related Videos

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

Related Experiment Videos

Last Updated: Jun 8, 2026

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

Area of Science:

Ophthalmology
Vascular Medicine

Background:

Retinal vein occlusion (RVO) is a prevalent vascular disorder with complex, multifactorial causes.
Despite extensive research, many aspects of RVO pathogenesis and management remain unclear, complicating treatment guideline development.

Purpose of the Study:

To clarify key aspects of retinal vein occlusion pathology.
To guide improved patient management strategies for RVO.

Main Methods:

Review of existing literature on RVO pathogenesis and treatment.
Analysis of current therapeutic approaches, including laser therapy and emerging intravitreal treatments.

Main Results:

Laser therapy, while a gold standard, shows limited functional improvement in branch RVO.
Intravitreal anti-VEGF agents, corticosteroids, and sustained-release implants are promising adjuncts to laser therapy.
A multidisciplinary approach is essential for managing RVO and addressing associated risk factors.

Conclusions:

Clarifying RVO pathology is crucial for optimizing patient care.
Combination therapies involving novel intravitreal agents represent the future of RVO management.
Addressing systemic and local risk factors is integral to successful RVO treatment.